Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease
Journal of Pharmacy and Pharmacology, 08/20/09
Strugala V et al. – GA can specifically remove both pepsin and bile acids from the refluxate, limit their diffusion and affect enzymatic activity of pepsin. There is a role for GA to reduce the damaging potential of the refluxate and thus protect the oesophagus.
Related Articles
Pepsin as a causal agent of inflammation during nonacidic reflux
Otolaryngology Head and Neck Surgery, 10/28/09
Relevance Score: 68%
Gastroesophageal Reflux Might Cause Esophagitis Through a Cytokine-Mediated Mechanism Rather Than Caustic Acid Injury
Gastroenterology, 10/28/09
Relevance Score: 67%
The effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease
Alimentary Pharmacology and Therapeutics, 11/03/09
Relevance Score: 66%
Globus sensation and increased upper esophageal sphincter pressure with distal esophageal acid perfusion
European Archives of Oto-Rhino-Laryngology, 11/06/09
Relevance Score: 65%
Sleep Apnea Sufferers at Risk for GI Conditions
Ivanhoe, 10/09/09
Relevance Score: 64%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
Journal of Viral Hepatitis, 12/17/09
Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy
Langenbeck's Archives of Surgery, 12/17/09
The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor